Bevirimat

DRUG2 trials

Sponsors

Myrexis Inc.

Conditions

HIV InfectionsHIV-1 Infection

Phase 2

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

CompletedNCT00511368

Myrexis Inc.HIV Infections

Start: 2006-04-30End: 2008-07-31Updated: 2010-01-20

A Phase 2 Study to Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days

CompletedNCT01097070

Myrexis Inc.HIV-1 Infection

Start: 2008-11-30End: 2009-01-31Updated: 2010-04-01